Published December, 2016
By Ernerio Alboliras
Publisher: John Wiley & Sons Ltd (Wiley–Blackwell)
Rating:
Availability: Not available (reason unspecified)

---

Published December, 2016
By Che J. Connon
Publisher: John Wiley & Sons Ltd (Wiley–Blackwell)
Rating:
Availability: Not available (reason unspecified)

The robust manufacture and supply of defined cells at commercially relevant scales is a clear requirement for the successful implementation of future cell based therapy.

---

Published November, 2016
By Nicolay Ferrari and Rosanne Seguin
Publisher: John Wiley & Sons Ltd (Wiley–Blackwell)
Rating:
Availability: Not available (reason unspecified)

Antisense–based drugs are part of a growing number of pharmaceutical and biotech programs to treat diseases including cancer, diabetes, and ALS. Reviewing fundamentals and offering guidelines for drug discovery and development, this book is a practical guide from the safety assessment to clinical experience with antisense oligonucleotides.

---

Published November, 2016
By John Plevris, Peter Hayes, Patrick Kamath, Louis-Michel Wong Kee Song and Louis–Michel Wong Kee Song
Publisher: John Wiley & Sons Ltd (Wiley–Blackwell)
Rating:
Availability: Not available (reason unspecified)

---

Published October, 2016
By Mike S. Lee, Ayman El-Kattan and Ayman El–Kattan
Publisher: John Wiley & Sons Ltd (Wiley–Blackwell)
Series: Wiley Series on Pharmaceutical Science and Biotechnology: Practices, Applications and Methods
Rating:
Availability: Not available (reason unspecified)

---

Published October, 2016
By Brian E. Leonard
Publisher: John Wiley & Sons Ltd (Wiley–Blackwell)
Rating:
Availability: Not available (reason unspecified)

---

Published October, 2016
By Kenneth J. Olivier and Sara A. Hurvitz
Publisher: John Wiley & Sons Ltd (Wiley–Blackwell)
Rating:
Availability: Not available (reason unspecified)

Providing practical and proven solutions for antibody–drug conjugate (ADC) drug discovery success in oncology, this book helps readers improve the drug safety and therapeutic efficacy of ADCs to kill targeted tumor cells.

---

Published October, 2016
By K. John Morrow, Jr., K. John Morrow and Cheng Liu
Publisher: John Wiley & Sons Ltd (Wiley–Blackwell)
Rating:
Availability: Not available (reason unspecified)

Addressing a significant need by describing the science and process involved to develop biosimilars of monoclonal antibody (mAb) drugs, this book covers all aspects of biosimilar development: preclinical, clinical, regulatory, manufacturing.

---

Published October, 2016
By Dennis A. Smith and Suzanne Iverson
Publisher: John Wiley & Sons Ltd (Wiley–Blackwell)
Rating:
Availability: Not available (reason unspecified)

A reference on drug metabolism and metabolite safety in the development phase, this book reviews the analytical techniques and experimental designs critical for metabolite studies. It features case studies of lessons learned and real world examples, along with regulatory perspectives from the US FDA and EMA.

---

Published October, 2016
By Deborah A Hall, Brandon Barton and Deborah Hall
Publisher: John Wiley & Sons Ltd (Wiley–Blackwell)
Series: NIP- Neurology in Practice
Rating: 4.00
Availability: Not available (reason unspecified)

---